Correction to “Efficacy and safety in tirzepatide‐treated Korean adults with type 2 diabetes—A post hoc analysis of SURPASS‐AP‐combo and SURPASS‐3”

Documents similaires

• Achieving normoglycaemia with tirzepatide: Post hoc exploratory analysis of the SURPASS J‐mono and J‐combo studies
  par: Kazuya Fujihara, et autres
  Publié: (2024)
• Efficacy and safety of tirzepatide in people with type 2 diabetes by baseline body mass index: An exploratory subgroup analysis of SURPASS‐AP‐Combo
  par: Jianhua Ma, et autres
  Publié: (2024)
• Decreased fatty liver index with tirzepatide treatment in Japanese patients with type 2 diabetes: A SURPASS J‐mono post hoc analysis
  par: Masato Yoneda, et autres
  Publié: (2025)
• Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the SURPASS clinical trial programme
  par: Brandon K. Bergman, et autres
  Publié: (2025)
• Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetes
  par: Djordje S. Popovic, et autres
  Publié: (2024)